Qiagen has entered into a co-marketing agreement with China's independent laboratory network, KingMed Diagnostics.
Under the agreement, KingMed Diagnostics will act as a centralized lab, allowing smaller hospitals and those in less-populated areas to provide the digene HPV test and send samples to its labs for processing and analysis.
Qiagen Asia Pacific president Victor Shi said by joining hands with KingMed Diagnostics the company can bring its lifesaving HPV testing technology not only to more women but also to the regions where it is most needed.
"We are pleased to work more closely with the leading provider of clinical diagnostic testing in China and to make progress towards saving more lives from cervical cancer," Shi added.